Category: Uncategorized

This week’s steep sell-off in the market’s reigning technology leaders could be a buying opportunity for investors, according to Morgan Stanley.

These dividend stocks are poised to move higher after the Federal Reserve starts cutting rates, says BMO.

Novo Nordisk saw price pressure for its GLP-1 drugs Ozempic and Wegovy. Investors want to know how Eli Lilly’s Zepbound performed.

Investors looking to sift through the sell-off should look for stocks that can withstand an economic shakeout, according to Citi.

David Keller breaks down the chart in Salesforce and gives key tips for buying beaten-up stocks.

The gold trade has held up better than riskier asset classes in August and could benefit from Fed rate cuts in the months ahead.

The Omaha-based conglomerate held $234.6 billion in short-term investments in Treasury bills by the end of the second quarter.

The market chaos this week has revived the debate about how to value bitcoin: Is it a risk asset or a hedge?

Tony Zhang breaks down how to use the market volatility to your advantage.

Here are Wednesday’s biggest calls on Wall Street.